These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 12726917

  • 1. Prevention of oxidant-induced cell death by lysosomotropic iron chelators.
    Persson HL, Yu Z, Tirosh O, Eaton JW, Brunk UT.
    Free Radic Biol Med; 2003 May 15; 34(10):1295-305. PubMed ID: 12726917
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Intralysosomal iron: a major determinant of oxidant-induced cell death.
    Yu Z, Persson HL, Eaton JW, Brunk UT.
    Free Radic Biol Med; 2003 May 15; 34(10):1243-52. PubMed ID: 12726912
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Intralysosomal iron chelation protects against oxidative stress-induced cellular damage.
    Kurz T, Gustafsson B, Brunk UT.
    FEBS J; 2006 Jul 15; 273(13):3106-17. PubMed ID: 16762036
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Cellular injury induced by oxidative stress is mediated through lysosomal damage.
    Ollinger K, Brunk UT.
    Free Radic Biol Med; 1995 Nov 15; 19(5):565-74. PubMed ID: 8529915
    [Abstract] [Full Text] [Related]

  • 8. Iron-dependent lysosomal destabilization initiates silica-induced apoptosis in murine macrophages.
    Persson HL.
    Toxicol Lett; 2005 Nov 15; 159(2):124-33. PubMed ID: 15949905
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Examination of the antiproliferative activity of iron chelators: multiple cellular targets and the different mechanism of action of triapine compared with desferrioxamine and the potent pyridoxal isonicotinoyl hydrazone analogue 311.
    Chaston TB, Lovejoy DB, Watts RN, Richardson DR.
    Clin Cancer Res; 2003 Jan 15; 9(1):402-14. PubMed ID: 12538494
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Involvement of p38 MAP kinase during iron chelator-mediated apoptotic cell death.
    Kim BS, Yoon KH, Oh HM, Choi EY, Kim SW, Han WC, Kim EA, Choi SC, Kim TH, Yun KJ, Kim EC, Lyou JH, Nah YH, Chung HT, Cha YN, Jun CD.
    Cell Immunol; 2002 Dec 15; 220(2):96-106. PubMed ID: 12657244
    [Abstract] [Full Text] [Related]

  • 17. α-Lipoic Acid-Plus Ameliorates Endothelial Injury by Inhibiting the Apoptosis Pathway Mediated by Intralysosomal Cathepsins in an In Vivo and In Vitro Endothelial Injury Model.
    Wang Y, Bao D, Dong Y, Wei X, Yu J, Niu C.
    Oxid Med Cell Longev; 2022 Dec 15; 2022():8979904. PubMed ID: 35450412
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Endosomal and lysosomal effects of desferrioxamine: protection of HeLa cells from hydrogen peroxide-induced DNA damage and induction of cell-cycle arrest.
    Doulias PT, Christoforidis S, Brunk UT, Galaris D.
    Free Radic Biol Med; 2003 Oct 01; 35(7):719-28. PubMed ID: 14583336
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.